Sun Pharmaceutical Industries Limited — Others, 06-05-2025: Change in Management

Sun Pharma has announced a board meeting to approve the superannuation of CFO Mr. C.S. Muralidharan effective 1 July 2025. He played a key role in finance transformation, supporting acquisitions, and advancing sustainability efforts. Ms. Jayashree Satagopan will take over as CFO from the same date. With over 30 years of experience across agri-solutions, healthcare, manufacturing, and automotive sectors, and recent CFO experience at Coromandel International, her appointment aims to ensure strong financial leadership as the company continues its growth trajectory.